Skip to main content
SANA
NASDAQ Life Sciences

Sana Posts $20.4M Q3 Profit on Contingent Consideration Gain, Cash Down to $121.7M

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.41
Mkt Cap
$700.504M
52W Low
$2.22
52W High
$5.49
52W Position info
8.6% above low
Off High info
56% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

SANA is trading near its 52-week low of $2.22 (8.6% above the low).

Summary

Sana reported Q3 2026 GAAP net income of $20.4 million, or $0.07 per share, versus a $42.2 million loss a year earlier — but the swing is almost entirely a $63.4 million non-cash gain from remeasuring success payment and Cobalt contingent consideration liabilities after the August 2026 amendment. Non-GAAP net loss was $43.0 million, or $0.14 per share, slightly wider than the $39.0 million loss in Q3 2025 as R&D rose to $33.9 million on SC451 and SG293 manufacturing costs. Cash, equivalents and marketable securities fell to $121.7 million from $138.4 million at year-end 2025, with the company guiding runway into mid-2027 — a tighter window than the mid-2027-plus framing that followed Q2, and the going-concern backdrop from the August 10-Q remains the key constraint. On the pipeline, Sana still expects to file the SC451 IND and start a Phase 1/2 type 1 diabetes trial as early as this year, with SG293 first-in-human data in non-Hodgkin lymphoma as early as the first half of 2027, and it published 14-month UP421 hypoimmune islet data in a NEJM Letter to the Editor. Watch the SC451 IND filing and trial start, which the company says could come before year-end.

At the time of this announcement, SANA was trading at $2.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $700.5M. The 52-week trading range was $2.22 to $5.49. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

SANA - Latest Insights

SANA
Nov 05, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.44
Real-time Price: $1.75 info
Change: -$0.6867 (-28%) info
Market Cap: $521.365M info
SANA
Sep 08, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.85
Real-time Price: $1.75 info
Change: -$2.09 (-54%) info
Market Cap: $521.365M info
SANA
Aug 10, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.53
Real-time Price: $1.75 info
Change: -$1.78 (-50%) info
Market Cap: $521.365M info
SANA
Aug 10, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.53
Real-time Price: $1.75 info
Change: -$1.78 (-50%) info
Market Cap: $521.365M info
SANA
Jul 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.73
Real-time Price: $1.75 info
Change: -$1.98 (-53%) info
Market Cap: $521.365M info